Fig. 3

Low-dose ASA decreased levels of 20 inflammatory proteins. Postmenopausal healthy women categorized as having BI-RADS D breast tissue were recruited from a regular mammography screening program and randomized to receive ASA 160 mg/day or no treatment for 6 months. Microdialysis was performed to sample inflammatory proteins locally in the left breast before and after treatment. A panel of 92 inflammatory proteins were quantified in the microdialysis samples using proximity extension assay. Out of these 92 proteins, 20 were significantly decreased in breast tissue. *p < 0.05, **p < 0.01, ***p < 0.001